Regenxbio Inc. (RGNX) PT Raised to $39 at Baird
Tweet Send to a Friend
Baird analyst Brian Skorney raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $39.00 (from $34.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
